• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

One for the ages: impact of age on international prognostic indices in lymphoid cancer.

作者信息

Brieghel Christian, Rotbain Emelie Curovic, Jelicic Jelena, Thorsteinsdottir Sigrun, Brown Peter de Nully, Niemann Carsten Utoft

机构信息

Department of Hematology, Rigshospitalet, Copenhagen, Denmark.

Hematology Branch, Danish Cancer Institute, Copenhagen, Denmark.

出版信息

Blood Adv. 2025 Aug 26;9(16):4260-4264. doi: 10.1182/bloodadvances.2025016534.

DOI:10.1182/bloodadvances.2025016534
PMID:40540808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12391784/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c66/12391784/313f01bf3929/BLOODA_ADV-2025-016534-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c66/12391784/ca537b6c584a/BLOODA_ADV-2025-016534-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c66/12391784/20e71b4d2f6b/BLOODA_ADV-2025-016534-gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c66/12391784/313f01bf3929/BLOODA_ADV-2025-016534-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c66/12391784/ca537b6c584a/BLOODA_ADV-2025-016534-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c66/12391784/20e71b4d2f6b/BLOODA_ADV-2025-016534-gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c66/12391784/313f01bf3929/BLOODA_ADV-2025-016534-gr2.jpg

相似文献

1
One for the ages: impact of age on international prognostic indices in lymphoid cancer.献给岁月的研究：年龄对淋巴癌国际预后指数的影响
Blood Adv. 2025 Aug 26;9(16):4260-4264. doi: 10.1182/bloodadvances.2025016534.
2
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
3
Multidimensional prognostic indices for use in COPD patient care. A systematic review.用于 COPD 患者护理的多维预后指标。系统评价。
Respir Res. 2011 Nov 14;12(1):151. doi: 10.1186/1465-9921-12-151.
4
Advanced Prediction of Heart Failure Risk in Elderly Diabetic and Hypertensive Patients Using Nine Machine Learning Models and Novel Composite Indices: Insights from NHANES 2003-2016.使用九种机器学习模型和新型复合指标对老年糖尿病和高血压患者心力衰竭风险的高级预测：来自2003 - 2016年美国国家健康与营养检查调查（NHANES）的见解
Eur J Prev Cardiol. 2025 Feb 27. doi: 10.1093/eurjpc/zwaf081.
5
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.乳腺密度、内分泌治疗与乳腺癌风险：预后和预测生物标志物综述。
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis.基因表达谱分析和扩展免疫组织化学检测在乳腺癌管理中指导辅助化疗的应用：系统评价和成本效益分析。
Health Technol Assess. 2013 Oct;17(44):1-302. doi: 10.3310/hta17440.
8
Prognostic value of albumin-based malnutritional indices on short-term outcome in acute ischemic stroke patients undergoing reperfusion therapy.基于白蛋白的营养不良指标对接受再灌注治疗的急性缺血性卒中患者短期预后的预测价值。
Front Nutr. 2025 Aug 4;12:1659446. doi: 10.3389/fnut.2025.1659446. eCollection 2025.
9
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study.自我报告的疲劳对骨髓增生异常综合征患者总生存预后的价值：一项多中心、前瞻性、观察性、队列研究。
Lancet Oncol. 2015 Nov;16(15):1506-1514. doi: 10.1016/S1470-2045(15)00206-5. Epub 2015 Sep 21.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

本文引用的文献

1
The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource: The Basis for Developing Data-Driven Hematology.丹麦淋巴瘤癌症研究（DALY-CARE）数据资源：发展数据驱动血液学的基础。
Clin Epidemiol. 2025 Feb 20;17:131-145. doi: 10.2147/CLEP.S479672. eCollection 2025.
2
What is ageing? Even the field's researchers can't agree.衰老是什么？就连该领域的研究人员也无法达成共识。
Nature. 2024 Dec;636(8042):283-284. doi: 10.1038/d41586-024-03936-8.
3
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia.
欧洲肿瘤内科学会（ESMO）慢性淋巴细胞白血病一线及复发时新型靶向治疗的临床实践指南临时更新
Ann Oncol. 2024 Sep;35(9):762-768. doi: 10.1016/j.annonc.2024.06.016. Epub 2024 Jul 3.
4
Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management.多发性骨髓瘤：2024 年关于诊断、风险分层和治疗的更新。
Am J Hematol. 2024 Sep;99(9):1802-1824. doi: 10.1002/ajh.27422. Epub 2024 Jun 28.
5
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models.弥漫性大 B 细胞淋巴瘤的预后指标：多种模型的基于人群的比较和验证研究。
Blood Cancer J. 2023 Oct 13;13(1):157. doi: 10.1038/s41408-023-00930-7.
6
Generalizability of landmark clinical trials in diffuse large B cell lymphoma to real-world patients: a single-center retrospective cohort study.弥漫性大B细胞淋巴瘤标志性临床试验对真实世界患者的可推广性：一项单中心回顾性队列研究
Leuk Lymphoma. 2022 Dec;63(12):2996-2999. doi: 10.1080/10428194.2022.2102620. Epub 2022 Jul 25.
7
The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials.大多数新诊断的骨髓瘤患者不符合III期临床试验的纳入标准。
Leukemia. 2019 Feb;33(2):546-549. doi: 10.1038/s41375-018-0272-0. Epub 2018 Sep 28.
8
Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.霍奇金淋巴瘤：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv19-iv29. doi: 10.1093/annonc/mdy080.
9
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.初治滤泡性淋巴瘤采用免疫化疗治疗的简化评分系统。
Blood. 2018 Jul 5;132(1):49-58. doi: 10.1182/blood-2017-11-816405. Epub 2018 Apr 17.
10
A MALT lymphoma prognostic index.MALT 淋巴瘤预后指数。
Blood. 2017 Sep 21;130(12):1409-1417. doi: 10.1182/blood-2017-03-771915. Epub 2017 Jul 18.